17 April 2018
Publication of Final Terms
The following Final Terms are available for viewing:
Final Terms dated 17 April 2018 (the "Final Terms") relating to the issue by AB Sveriges Säkerställda Obligationer (publ) (The Swedish Covered Bond Corporation) ("SCBC") of €500,000,000 1.250 per cent. Covered Notes due 19 April 2033 (Extendible to 19 April 2034) (the "Notes") pursuant to its €16,000,000,000 Euro Medium Term Covered Note Programme (the "Programme").
The Final Terms contain the final terms of the Notes and must be read in conjunction with the Prospectus dated 16 June 2017, as supplemented by the supplements to it dated 19 July 2017, 10 October 2017 and 16 February 2018 relating to the Programme (the "Prospectus"). The Prospectus constitutes a base prospectus for the purposes of Article 5.4 of Directive 2003/71/EC (as amended, including by Directive 2010/73/EU). Full information on SCBC and the offer of the Notes is only available on the basis of the combination of the Prospectus and the Final Terms.
Please read the section "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.
The managers in respect of the Notes are:
Joint Lead Managers
ABN AMRO Bank N.V.
Citigroup Global Markets Limited
Credit Suisse Securities (Europe) Limited
Danske Bank A/S
Goldman Sachs International
DekaBank Deutsche Girozentrale
Norddeutsche Landesbank - Girozentrale -
To view the Final Terms, please paste the following URL into the address bar of your browser.
For further information, please contact:
Elise Avsan, SBAB Bank AB (publ)
Karl Königsson, SBAB Bank AB (publ)
Tel: +46 (0)8 614 38 78
Tel: +46 (0)8 614 43 95
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Prospectus and the Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus and the Final Terms is not addressed. Prior to relying on the information contained in the Prospectus and the Final Terms, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.
This publication does not constitute an offering of the securities described in the Prospectus and the Final Terms for sale in the United States. This is not for distribution in the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act") or under any relevant securities laws of any state of the United States and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States.
This information is provided by RNS